This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Anne Colston Wentz, MD; George R. Huggins, MD

JAMA. 1994;271(21):1689-1691.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Contraceptive development has taken a new direction in the face of the acquired immunodeficiency syndrome epidemic, the high incidence of teenage pregnancy, and the need for acceptable, female-controlled family planning methods. Sexually transmitted diseases (STDs) are a particular problem, as women suffer most of their consequences, including pelvic inflammatory disease, infertility, and tubal pregnancy. Heterosexual transmission of human immunodeficiency virus (HIV) accounts for the alarming increase in its incidence in reproductive-age women. Thus, new contraceptive strategies must be sought. Needed is a safe, female-controlled method that would be effective in preventing both pregnancy and the transmission of STDs, including HIV.

The female condom is a welcome addition, but its contraceptive and STD prevention efficacy need further study. There is an 11% to 15% rate of accidental pregnancy at 6 months for women who use the the female condom (similar to rates for other barrier contraceptive methods for women); however, rates . . . [Full Text PDF of this Article]

Author Affiliations
Northwestern University Medical School, Chicago, Ill; The Johns Hopkins University School of Medicine, Baltimore, Md

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?